NASDAQ: JBIO
Jade Biosciences Inc Stock Ownership - Who owns Jade Biosciences?

Insider buying vs selling

Have Jade Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Fairmount Funds Management LLCDirector2025-10-061,333,126$9.14
$12.18MBuy
Tom FrohlichChief Executive Officer2025-05-166,000$7.40
$44.40kBuy

1 of 1

JBIO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when JBIO insiders and whales buy or sell their stock.

JBIO Shareholders

What type of owners hold Jade Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC14.82%4,835,383$47.31MInstitution
Fairmount Funds Management LLC13.96%4,553,494$44.56MInsider
Sofinnova Venture Partners X LP11.52%3,758,686$36.78MInsider
Maha Katabi11.52%3,758,686$36.78MInsider
Fairmount Funds Management LLC9.87%3,220,368$31.51MInstitution
Vr Adviser LLC9.87%3,220,364$31.51MInstitution
Deep Track Capital LP7.69%2,509,301$24.55MInstitution
Atlas Venture Fund XII LP7.13%2,327,909$22.78MInsider
Cormorant Asset Management LP6.22%2,030,691$19.87MInsider
Vanguard Group Inc5.54%1,807,582$17.69MInstitution

1 of 3

JBIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
JBIO62.49%37.51%Net BuyingNet Buying
SLN13.95%0.09%
ALEC59.85%40.15%Net SellingNet Selling
IMMP0.12%0.00%
VNDA52.50%47.50%Net SellingNet Buying

Jade Biosciences Stock Ownership FAQ

Who owns Jade Biosciences?

Jade Biosciences (NASDAQ: JBIO) is owned by 96.72% institutional shareholders, 58.06% Jade Biosciences insiders, and 0.00% retail investors. Fairmount Funds Management LLC is the largest individual Jade Biosciences shareholder, owning 4.55M shares representing 13.96% of the company. Fairmount Funds Management LLC's Jade Biosciences shares are currently valued at $42.67M.

If you're new to stock investing, here's how to buy Jade Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.